US regulators are making a point of going after corporations that invest in companies where there is a perceived competitive overlap.

AbbVie is acquiring Amgen-backed DJS Antibodies for $255m while Legend Holdings took part in a $56.6m series C round for VectorBuilder.

Alexandria Real Estate-backed Acrivon has filed to go public while H2 Green Steel increased its corporate-backed series B round to $255m.

Tencent took part in a $400m round for Skydance Media while CrowdStrike helped Vanta hike its series B to $150m.

Rakuten-backed Base Food is set to list on TSE’s Growth Market in an IPO valuing it at $329m while Mitsui was part of a $400m round for Yellow Door Energy.

Consumer credit provider FinAccel secured $140m from investors including GMO Payment Gateway while Amgen helped brain disease drug developer Neumora raise $112m.

BBC Studios bought portfolio company Firebird Pictures while SoftBank Vision Fund 2 led a nine-figure round for dental product maker SprintRay.

Strong branding helped give a canned water producer reach a $700m valuation while the promise of long-term energy storage fueled a $450m mega round.

Q2 Holdings has acquired National Bank of Canada and OpenText-backed Sensibill while ArcelorMittal's XCarb unit was part of Form Energy’s $450m series E round.

Solid Biosciences is merging with Sarepta-backed AavantiBio in a $215m deal while Amazon has formed a minority founder-focused $150m fund.